These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22074929)

  • 21. Activated mTORC1 promotes long-term cone survival in retinitis pigmentosa mice.
    Venkatesh A; Ma S; Le YZ; Hall MN; Rüegg MA; Punzo C
    J Clin Invest; 2015 Apr; 125(4):1446-58. PubMed ID: 25798619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-syndromic retinitis pigmentosa.
    Verbakel SK; van Huet RAC; Boon CJF; den Hollander AI; Collin RWJ; Klaver CCW; Hoyng CB; Roepman R; Klevering BJ
    Prog Retin Eye Res; 2018 Sep; 66():157-186. PubMed ID: 29597005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of vision loss and delay in apoptosis of photoreceptors induced by proinsulin in a mouse model of retinitis pigmentosa.
    Corrochano S; Barhoum R; Boya P; Arroba AI; Rodríguez-Muela N; Gómez-Vicente V; Bosch F; de Pablo F; de la Villa P; de la Rosa EJ
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4188-94. PubMed ID: 18515565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optogenetic therapy for retinitis pigmentosa.
    Busskamp V; Picaud S; Sahel JA; Roska B
    Gene Ther; 2012 Feb; 19(2):169-75. PubMed ID: 21993174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa.
    Schön C; Becirovic E; Biel M; Michalakis S
    Methods Mol Biol; 2018; 1715():33-46. PubMed ID: 29188504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease.
    Giacalone JC; Wiley LA; Burnight ER; Songstad AE; Mullins RF; Stone EM; Tucker BA
    Stem Cells Transl Med; 2016 Feb; 5(2):132-40. PubMed ID: 26683869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease.
    Ramachandran PS; Song JY; Bennett J
    J Clin Invest; 2015 Apr; 125(4):1390-2. PubMed ID: 25798615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bardet-Biedl Syndrome in rhesus macaques: A nonhuman primate model of retinitis pigmentosa.
    Peterson SM; McGill TJ; Puthussery T; Stoddard J; Renner L; Lewis AD; Colgin LMA; Gayet J; Wang X; Prongay K; Cullin C; Dozier BL; Ferguson B; Neuringer M
    Exp Eye Res; 2019 Dec; 189():107825. PubMed ID: 31589838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell dysfunction in inherited blindness.
    Lolley RN
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():438-43. PubMed ID: 6589860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.
    Cai X; Conley SM; Nash Z; Fliesler SJ; Cooper MJ; Naash MI
    FASEB J; 2010 Apr; 24(4):1178-91. PubMed ID: 19952284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in treatment of retinitis pigmentosa.
    He Y; Zhang Y; Su G
    Curr Stem Cell Res Ther; 2015; 10(3):258-65. PubMed ID: 25345673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration.
    Zhang L; Du J; Justus S; Hsu CW; Bonet-Ponce L; Wu WH; Tsai YT; Wu WP; Jia Y; Duong JK; Mahajan VB; Lin CS; Wang S; Hurley JB; Tsang SH
    J Clin Invest; 2016 Dec; 126(12):4659-4673. PubMed ID: 27841758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mathematical models of retinitis pigmentosa: The oxygen toxicity hypothesis.
    Roberts PA; Gaffney EA; Luthert PJ; Foss AJE; Byrne HM
    J Theor Biol; 2017 Jul; 425():53-71. PubMed ID: 28483568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa.
    Shen J; Yang X; Dong A; Petters RM; Peng YW; Wong F; Campochiaro PA
    J Cell Physiol; 2005 Jun; 203(3):457-64. PubMed ID: 15744744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term rescue of cone photoreceptor degeneration in retinitis pigmentosa 2 (RP2)-knockout mice by gene replacement therapy.
    Mookherjee S; Hiriyanna S; Kaneshiro K; Li L; Li Y; Li W; Qian H; Li T; Khanna H; Colosi P; Swaroop A; Wu Z
    Hum Mol Genet; 2015 Nov; 24(22):6446-58. PubMed ID: 26358772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantifying the metabolic contribution to photoreceptor death in retinitis pigmentosa via a mathematical model.
    Camacho ET; Punzo C; Wirkus SA
    J Theor Biol; 2016 Nov; 408():75-87. PubMed ID: 27519951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ℮-conome: an automated tissue counting platform of cone photoreceptors for rodent models of retinitis pigmentosa.
    Clérin E; Wicker N; Mohand-Saïd S; Poch O; Sahel JA; Léveillard T
    BMC Ophthalmol; 2011 Dec; 11():38. PubMed ID: 22185426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach.
    Petersen-Jones SM; Occelli LM; Winkler PA; Lee W; Sparrow JR; Tsukikawa M; Boye SL; Chiodo V; Capasso JE; Becirovic E; Schön C; Seeliger MW; Levin AV; Michalakis S; Hauswirth WW; Tsang SH
    J Clin Invest; 2018 Jan; 128(1):190-206. PubMed ID: 29202463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative Stress and Microglial Response in Retinitis Pigmentosa.
    Murakami Y; Nakabeppu Y; Sonoda KH
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.